Skip to content

Use-result survey of GOBIK Aqueous Suspension Syringes

Use-result survey of GOBIK Aqueous Suspension Syringes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT2061240030
Enrollment
1500
Registered
2024-07-04
Start date
2024-07-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of pertussis,diphtheria,tetanus,poliomyelitis and invasive disease due to Hib infections

Interventions

None listed

Sponsors

Fujii Takeshi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children who have received the vaccine as primary immunization or booster immunization

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
safety:Rate of vaccine-related adverse event, Factors that may influence safety, Rate of serious vaccine-related adverse event

Contacts

Public ContactTakeshi Fujii

The Research Foundation for Microbial Diseases of Osaka University

gpsp@mail.biken.or.jp+81-875-25-4835

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026